Navigation Links
The German National Academy of Sciences Leopoldina makes recommendations for the G8 summit
Date:5/29/2013

In the run up to the G8 summit in Lough Erne, Northern Ireland, the German National Academy of Sciences Leopoldina, in partnership with the national science academies of the G8 member states and five other science academies, is calling on the heads of state and government of the eight leading industrialised nations to focus their attention on two topics in the immediate future: drug-resistant infectious agents and sustainable development. The academies' statements will be handed to the participating governments before the summit on 17 and 18 June so that their recommendations can be incorporated into the negotiations.

Infectious agents that are resistant to drugs represent one of the greatest threats to the human population worldwide -- this is the thesis of the statement "Drug Resistance in Infectious Agents -- A Global Threat to Humanity". People are increasingly being infected with resistant pathogens, and more and more often the drugs used to treat them, such as antibiotics, are not working. The academies also warn that the number of multi-drug-resistant infections acquired in hospital settings is on the rise. "The development of drugs that can fight infectious diseases is one of the greatest achievements of modern medicine," says Leopoldina President Prof. Jrg Hacker. "But in order for future generations to profit from this achievement, we urgently need to address the problem of drug resistance. New drugs cannot be developed over night, yet we are already faced with a growing number of patients infected with drug-resistant agents for whom no treatment is available. This presents all of society with a big challenge, and that is why this topic must be included on the political agenda."

The academies recommend a more considered approach to current and future drugs, with strategies defined in guidelines issued by each G8 member, in order to ensure that these drugs remain effective for longer. The academies stress the importance of the following measures:

  • A more responsible approach to drug prescription for human use
  • Reduced use of antibiotics and other drugs in animal husbandry
  • Incentives for pharmaceutical companies to develop new drugs to fight infectious disease, especially new antibiotics
  • Information and education programmes
  • A global system of control to combat the spread of resistant microorganisms

In the statement "Driving Sustainable Development: the Role of Science, Technology and Innovation", the academies explain how science and research can contribute to ensuring sustainable development. The statement asserts that many of the most pressing global challenges can only be met through a systematic approach and by including the global scientific community in the relevant processes. This is particularly true for population growth, the sustainable use of resources, and the supply of water, food and energy. A further important prerequisite for sustainable development is improved literacy. The academies recommend promoting literacy across the globe, and advocate the importance of adopting a wider understanding of the term in this context to include scientific literacy, for example with regard to knowledge about nutrition and healthcare.


'/>"/>

Contact: Dr. Marina Koch-Krumrei
internationalrelations@leopoldina.org
49-034-547-239-833
Leopoldina
Source:Eurekalert

Related biology news :

1. Bowman Design Group is first US company awarded German FAMAB Sustainable Company certification
2. Specialised germanium surface as universal protein adapter
3. German Research Foundation to fund globally unique twin study on social inequality
4. Newly discovered letters and translated German ode expand Texas link to infamous Bone Wars
5. When do German children gain weight?
6. German National Academy of Sciences issues a critical statement on the use of bioenergy
7. Copernicus Award 2012 for German-Polish collaboration in business information systems
8. CARE Pharmacies Joins National Association of Specialty Pharmacy (NASP) as a Founding Corporate Member
9. Save the date: American Chemical Society National Meeting, Sept. 8-12, 2013, in Indianapolis
10. 2 UCLA faculty elected to National Academy of Sciences
11. Ophthalmologist Inventors of Human Identification Technology Inducted into National Inventors Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited the ... the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... largest German biometrics company the two government leaders could see the three ... as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
(Date:3/13/2017)... 13, 2017 Future of security: Biometric Face Matching software  ... ... DERMALOGs Face Matching enables to match face pictures against each other ... identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face Matching on the ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... 2017   Sienna Biopharmaceuticals, Inc. , a privately ... that Richard Peterson will join the company ... Peterson, who brings more than two decades of global ... is retiring at the end of April but will ... joins Sienna from Novan, Inc., where he served as ...
(Date:3/23/2017)... BETHESDA, Md. , March 23, 2017 /PRNewswire/ ... company developing DCVax® personalized immune therapies for solid ... on the $7.5 million financing it announced last ... Company sold to several institutional investors securities totaling ... $.26 per share, and 10,000,000 shares of Class ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced ... the hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business ... joint development activities. , “Dr. Floyd’s career has spanned 30 years in the ...
Breaking Biology Technology: